News

February 21, 2012 – Dr. Matt Mealiffe from Evinome participates on a panel as part of an invited group of clinicians active in social media and blogging at the HIMSS12 Annual Conference.

January 9, 2012 – Evinome begins taking preorders for the upcoming BRCAscoop 2011 Hereditary Breast and Ovarian Cancer Research Report via a novel “Pay-What-You-Want” approach that maintains access for anyone who will benefit (regardless of ability to pay), while providing important support to key nonprofits in the Hereditary Breast and Ovarian Cancer ecosystem too.

July 4, 2011 – Evinome is currently pilot testing The BRCAscoop Update - a new ultra high quality, paid subscription monthly health information update for women and men with Hereditary Breast and Ovarian Cancer risk due to BRCA1 and BRCA2 mutations

July 4, 2011 – Evinome has launched the BRCAscoop Blog, which will feature brief summaries of important newly published research relevant to women and men with Hereditary Breast and Ovarian Cancer risk due to BRCA1 and BRCA2 mutations

July 4, 2011 – Evinome has launched BRCAscoop.com – an important new resource for individuals with Hereditary Breast and Ovarian Cancer risk due to BRCA1 and BRCA2 mutations

March 14, 2011 – Dr. Matt Mealiffe from Evinome will be attending the 2011 ACMG Annual Clinical Genetics Meeting in Vancouver, BC, Canada from March 16-20, 2011.

March 3-4, 2011 – Dr. Matt Mealiffe from Evinome attended the Future of Genomic Medicine IV Meeting in La Jolla, CA.

February 23, 2011 – Dr. Matt Mealiffe to Discuss Evinome at FountainBlue’s Life Science Entrepreneur’s Forum titled “Medical Diagnostics: The Advancements and the Opportunities” on February 28, 2011